Prevention and treatment of ovarian hyperstimulation syndrome
- 17 April 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 17 (2) , 249-261
- https://doi.org/10.1016/s1521-6934(02)00127-x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- GnRH antagonist in assisted reproduction: a Cochrane reviewHuman Reproduction, 2002
- Ovarian hyperstimulation syndrome: an endocrinopathy?Current Opinion in Obstetrics and Gynecology, 2001
- Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patientsHuman Reproduction, 2001
- Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III studyHuman Reproduction, 2000
- The ovarian hyperstimulation syndromeFertility and Sterility, 2000
- Distinction between early and late ovarian hyperstimulation syndromeFertility and Sterility, 2000
- Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilizationFertility and Sterility, 1999
- The role of luteal phase support in infertility treatment: a meta-analysis of randomized trialsFertility and Sterility, 1994
- Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors*Human Reproduction, 1994
- Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles**Supported in part by the Schreiber Foundation, Tel-Aviv University.Fertility and Sterility, 1987